Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

CVDT 2018

About Conference

The International Conference on Cardiovascular Diseases and Therapeutics will be held in Paris, France during November 21-22, 2018 organized by CVDT 2018. Cardiology Conferences will lay a platform for scientists, world-class professors, and cardiologists to discuss an approach for cardiovascular diseases. International Cardiology Conferences is designed to provide present research information that will keep medical professionals alongside of the issues affecting the diagnosis, treatment of Cardiac disorders and prevention. In recent years, cardiac and vascular devices have been developed which helped for the treatment of cardiac disorders, replacement and repair therapy. Cardiology conferences organizes 1000+ Global events each year across the globe with support from 1000+ more scientific societies and Publishes 500 Open access journals which contains over 50000 eminent personalities, reputed physicians and scientists as editorial board members.

The field incorporates therapeutic analysis and treatment of coronary vein infection, Cardiac imperfections, valvular coronary illness, heart disappointment and electrophysiology. Cardiology is concerned with the characteristic usefulness of the heart and discrepancy from a normal heart. Numerous issues include the heart itself yet some are outside of the heart.

CVDT 2018 welcomes the, Professors, Research scholars, Industrial Professionals, Cardiac surgeons, Cardiologists, physicians, and student delegates from cardiology and healthcare sectors to be a part of it.

Why to attend??? 

The International Conference on Cardiovascular Diseases and Therapeutics is among the World’s leading Cardiology Conference. This CVDT 2018 will disperse information, and meet with recurring pattern and potential investigators and get name affirmation at this 2-day event. Broadly acclaimed speakers, the most recent frameworks, methodologies, and the most current updates in Cardiology field are indications of this conference. This year conference will comprises of major sessions designed to offer comprehensive sessions that address current issues in various field of Cardiovascular & cardiac diseases. The benefits provided to the attendees are:

  • Certificates will be provided to all speakers, delegates and students
  • Opportunity to meet world’s renowned at this event
  • Keynote forums by Prominent Physicians & Professors
  • Best platform for Global business and networking opportunities
  • Oral/Poster presentations by Young Researchers
  • Best poster award for students


Market Analysis

Top five drivers of cardiovascular market growth

Total sales for cardiovascular diseases will grow steadily over the next six years, reaching about $60B in 2023. The top five major drivers of this growth will be two anticoagulants (Bristol-Myers Squibb’s [BMS’] Eliquis [apixaban]‎ and Johnson & Johnson [J&J]/Bayer’s Xarelto [rivaroxaban]), a heart failure drug (Novartis’s Entresto [sacubitril/valsartan]) and two drugs for pulmonary arterial hypertension (J&J’s Opsumit [macitentan] and Uptravi [selexipag]). These five drugs will represent 50% of the total cardiovascular market in 2023, while Eliquis and Xarelto alone will represent 36% of the whole cardiovascular market. Cholesterol-lowering drugs were not part of this analysis, as they were considered to be part of the metabolic disorders therapeutic area.

Global cardiovascular devices market is anticipated to reach USD 121 billion by 2024, according to a new report by Grand View Research, Inc. Increasing geriatric population, sedentary life style coupled with unhealthy dietary habits is spurring the prevalence of cardiovascular diseases. Constant rise in the patients suffering from cardiovascular diseases and is expected to drive market growth during the forecast period.

Governments are trying to limit hospital readmissions to reduce the prevalence of hospital acquired infections (HAIs) by imposing penalties on hospitals. As a result, adoption of home healthcare, remote patient monitoring, and long term care services is rapidly increasing. Thus, demand for cardiovascular devices is increasing from hospitals, patients based in home settings, and long term care centers.

In addition, favorable government policies such as reimbursement coverage are fueling adoption of these devices. Thus, increasing target patient population, rising acceptance of home healthcare, and favorable government policies are some of the major factors driving the growth of the global cardiovascular devices market.

On the other hand, high device cost and stringent regulatory approval procedure are some of the prime factors challenging the growth of the market. In addition, lack of skilled professionals to perform surgical procedures using advanced devices is impeding the adoption of new devices.

The global cardiac monitoring market is expected to register a CAGR of around 4%. North America accounted for the highest market value in 2017. However, Middle East & Africa is expected to register the highest CAGR during the forecast period.

Cardiovascular diseases have become one of the primary reasons for mortality and are becoming a major concern in most parts of the world. Coronary heart disease (CHD) is the most common type of heart disease, with a death toll of more than 370,000 people annually. The American Heart Association (AHA) reports cardiovascular disease to be the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. The Heart Foundation also states that CVD is a major cause of death in Australia, with 45,053 deaths attributed to CVD in the country, in 2014.

Annual Market Size Forecats by Geographic Region:

Market Segmentation:

Segment 1: ECG Systems

Segment 2: Hoter Monitors

Sement 3: Implantable Loop Recorders

Segment 4: Others

Conference Sessions

Past Conference Report

Euro Cardiology 2017

In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects of clinical skills, Cardiology conferences 20th European Cardiology Conference was held during October 16-18, 2017 in Budapest, Hungary.

Cardiology conferences Group played host to a diverse panel of key members of the Euro Cardiology 2017 community from research lab, industry, academia and financial investment practices, discussing the future of Cardiology and Cardiovascular specialties. This event was really aimed for examining where the real cardio-logical specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Cardiology.

Focusing on Cardiology, Interventional Cardiology, Cardiac Stroke, Clinical Cardiology, Heart Diseases, Cardiac Surgery, Coronary Heart Diseases, Cardiac Rhythm Abnormalities, Pediatric Cardiology, Cardiomyopathies, Vascular Biology, Cardiac Regeneration, Case reports on Cardiology, Cardiac Diagnostic & Tests, Cardiac Remodelling or Ventricular Remodelling, Myocardial Infarction, Hypertension, Cardiovascular Disease and Nutrition, Cardiac Nursing, Cardiovascular Pharmacology, Molecular Cardiology as well, the two days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Euro Cardiology 2017 Organizing Committee would like to thank the Moderator of the conference, Dr. Maria Kalliopi Konstantinidou, Royal Brompton and Harefield NHS Trust, UK, Dr. Marco Picichè, San Camillo-Forlanini Hospital, Italy and Dr. Antonis Armoundas, Massachusetts General Hospital, USA who contributed a lot for the smooth functioning of this event.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by Honourable Guests and members of the Keynote forum. The highlights of the meeting were the eponymous lectures, delivered by:

József Balla, University of Debrecen, Hungary

Marco Piciche , San Camillo-Forlanini Hospital, Italy

Antonis Armoundas, Massachusetts General Hospital, USA

Pablo Rodenas, Rosario Gamma Group, Argentina

Tomohiro Asahi, Naha City Hospital, Japan

Regina Célia Spadari, Universidade Federal de Sao Paulo, Brazil

Dimitrios Protogeros, Cardiac Surgeon, Greece          

These talks were of great interest to the general cardiologists and were enormously informative.

We are happy to announce our International Conference on Cardiovascular Diseases and Therapeutics, which will be held during November 21-22, 2018 Paris, France.

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 21-22, 2018

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

Journal of Cardiovascular Diseases & Diagnosis Journal of Clinical & Experimental Cardiology Cardiovascular Pharmacology: Open Access

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


  • Diabetes And The Heart
  • Diabetes, Obesity & Stroke
  • Diagnosis And Pathophysiology Of Hypertension
  • Diet And Exercise For Hypertension
  • Diet And Lifestyle In Hypertension Management
  • Dietary And Cardiovascular Risk
  • Echocardiography
  • Evaluation Of Hypertension
  • Genetic Cardiology
  • Health Informatics & Nutrition
  • Heart Regeneration And Diagnosis
  • High Blood Pressure And Kidney Diseases
  • Hypertension Treatments
  • Hypertension, Stress And Stroke
  • Interventional Cardiology
  • Molecular Cardiology
  • Nuclear Cardiology
  • Nuclear Cardiology & Cardiac CT
  • Nursing Management Of Hypertension
  • Obesity And Heart
  • Oncology & Public Health
  • Pediatric & Geriatric Cardiology